Clinical Trial Update: Multi-level Determinants of Starting ART Late: Aim 3

View source ↗

Summary

This completed clinical trial update summarizes Aim 3 of a study examining multilevel determinants of starting antiretroviral therapy late in people with HIV in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: Columbia University | Conditions: Human Immunodeficiency Virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) | Status: COMPLETED